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648Objective: Hospitals with a high volume and academic status produce better patient outcomes than other hos-
pitals after complex surgical procedures. Risk models show that concomitant aortic valve replacement and cor-
onary artery bypass grafting pose a greater risk than isolated coronary artery bypass grafting or aortic valve
replacement. We examined the relationship of hospital teaching status and the presence of a thoracic surgery
residency program with aortic valve replacement/coronary artery bypass grafting outcomes.
Methods: By using the Nationwide Inpatient Sample database, we identified patients who underwent concom-
itant aortic valve replacement/coronary artery bypass grafting from 1998 to 2007 at nonteaching hospitals,
teaching hospitals without a thoracic surgery residency program, and teaching hospitals with a thoracic surgery
residency program. Multivariate analysis was performed to identify intergroup differences. Risk-adjusted mul-
tivariable logistic regression analysis was used to assess independent predictors of in-hospital mortality and
complication rates.
Results: The 3 groups of patients did not differ significantly in their baseline characteristics. Patients who un-
derwent aortic valve replacement/coronary artery bypass grafting had higher overall risk-adjusted complication
rates in nonteaching hospitals (odds ratio 1.58; 95% confidence interval, 1.39–1.80; P<.0001) and teaching
hospitals without a thoracic surgery residency program (odds ratio 1.42; 95% confidence interval, 1.26–1.60;
P<.0001) than in thoracic surgery residency program hospitals. However, no difference was observed in the
adjusted mortality rate for nonteaching hospitals (odds ratio 0.95; 95% confidence interval, 0.87–1.04;
P ¼ .25) or teaching hospitals without a thoracic surgery residency program (odds ratio 1.00; 95% confidence
interval, 0.92–1.08; P ¼ .98) when compared with thoracic surgery residency program hospitals. Robust statis-
tical models were used for analysis, with c-statistics of 0.98 (complications) and 0.82 (mortality).
Conclusion: Patients who require complex cardiac operations may have better outcomes when treated at teach-
ing hospitals with a thoracic surgery residency program. (J Thorac Cardiovasc Surg 2012;143:648-55)Better patient outcomes have been reported when complex
surgical procedures (eg, esophagectomies and repairs of
thoracoabdominal aortic aneurysm and aortic dissection)
are performed at high-volume centers and those with aca-
demic affiliations.1-3 However, in the past decade, surgical
training at academic centers has faced challenges and has
been a constant subject of scrutiny. In cardiac surgery,
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The Journal of Thoracic and Cardiovascular Surgartery bypass grafting (CABG) have decreased in volume
because of advancements in percutaneous interventions.
Today, many more complex cardiac surgical procedures
are performed that often involve a combination of a valve
operation and myocardial revascularization. This, along
with the 80-hour work-week restriction on surgical resi-
dents, has accentuated the difficulties associated with car-
diothoracic surgical training. Despite the challenges
facing academic surgical centers and surgical training pro-
grams, we hypothesize that academic centers provide better
care for patients who undergo more complex cardiac
procedures.
We sought to examine the relationship between the pres-
ence of a thoracic surgery residency program (TSRP) and
the outcomes of a complex cardiac surgical procedure—
concomitant aortic valve replacement (AVR) and CABG.MATERIAL AND METHODS
Data Source
Data were obtained from the US Nationwide Inpatient Sample (NIS);
these data were collected from 1998 to 2007. The NIS is a databaseery c March 2012
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
HCUP ¼ Healthcare Cost and Utilization
Project
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9-CM
¼ International Classification of
Diseases, Ninth Revision, Clinical
Modification
NIS ¼ Nationwide Inpatient Sample
OR ¼ odds ratio
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Dcontaining records of hospital inpatient stays and is maintained by the
Agency for Healthcare Research and Quality as part of the Healthcare
Cost and Utilization Project (HCUP).4 A 10-year time span was chosen
so that any trends that might have occurred during that time period
would probably have affected teaching and nonteaching hospitals
uniformly.
The NIS, the largest all-payer inpatient care database, represents
20% of all hospital discharges from nonfederal facilities in the United
States and thus was particularly suited for testing our hypothesis. The
NIS has numerous internal quality assurance procedures for checking
the consistency and validity of data (http://www.hcup-us.ahrq.gov/db/
quality.jsp). Furthermore, HCUP validates the NIS annually by compar-
ing its contents with those of 2 similar databases— the National Hospital
Discharge Survey and the Medicare Provider Analysis and Review—to
assess potential biases in the data (http://www.hcup-us.ahrq.gov/db/
nation/nis/nisrelatedreports.jsp). The NIS contains data from more
than 1000 hospitals regarding approximately 8 million hospital stays
each year, although this number varies slightly on an annual basis.
Weights based on sampling probabilities for each stratum are used in
the analysis to ensure that the hospitals studied are representative of
all US hospitals.
A teaching hospital was defined by the NIS as one with an active teach-
ing residency program, regardless of subspecialty. The NIS hospital core
files were used to tally the name of the hospital against the hospitals listed
in the fellowship and residency interactive electronic database under the
category of thoracic surgery residency. Specifically, the participating hos-
pital rather than the sponsoring program was tallied to ensure that all hos-
pitals that support a TSRP were captured. For the teaching hospital group,
cases in which the hospital name and address were not available were ex-
cluded from the study. We stratified our samples into 3 groups: non-
teaching hospitals, teaching hospitals without a TSRP, and hospitals with
a TSRP.
Variables available in the NIS included patient and hospital demograph-
ics, payer information, treating and concomitant diagnoses, inpatient pro-
cedures, in-hospital mortality, and length of hospital stay (date of
admission to date of discharge). For each admission, the NIS captures up
to 15 diagnosis and procedure codes from the International Classification
of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).5 In addi-
tion, the NIS hospital core files allow us to correct for potentially confound-
ing hospital characteristics.
This study was approved by the institutional review board of Baylor
College of Medicine. The data reported in our study conform to the Data
Use Agreement for the NIS from the HCUP. Additional information about
the NIS is available from the Agency for Healthcare Research and Quality,
which sponsors the database as part of the HCUP (http://www.hcup-us.
ahrq.gov/nisoverview.jsp).The Journal of Thoracic and CaPatient Selection
We used ICD-9-CM procedure codes to query the entire NIS data set
and identify all patients who underwent concomitant AVR/CABG opera-
tions from 1998 to 2007. The ICD-9-CM procedure codes 3610, 3612,
3613, 3614, 3615, and 3616 were used to select patients who underwent
CABG procedures; among this subset of patients, the codes for AVR
(3521, 3522) were used to select patients who had concomitant AVR/
CABG. Patients who underwent other concomitant valve operations or
other noncoronary cardiac procedures (Table 1) and those who were aged
less than 18 years were excluded. A total of 202,663 cases of AVR/
CABG were identified, of which 65,407 were performed in nonteaching
hospitals, 24,125 were performed in TSRP hospitals, and 83, 414 were per-
formed in teaching hospitals without a TSRP; 29,717 cases (14.7%) from
136 teaching hospitals were excluded because TSRP status was not known.
Of the 740 hospitals where AVR/CABG procedures were performed,
43.1% were nonteaching hospitals (n¼ 319). Of the remaining 285 teach-
ing hospitals, 61 supported a TSRP approved by the Accreditation Council
for Graduate Medical Education.
Patient Characteristics
The Deyo index6 was used to compare the 3 groups of patients in terms
of preoperative morbidity. Specifically designed to be used with adminis-
trative databases, the Deyo index is a weighted comorbidity index that is
modified from the Charlson comorbidity index and that assesses 17 prespe-
cified comorbidities. Furthermore, the Deyo index uses more than 600
ICD-9 diagnosis codes to query specific comorbid diagnoses.
Previously, we demonstrated the feasibility of querying the NIS data-
base for cardiac surgical procedures.7,8 Patient comorbidities were
identified from each patient’s ICD-9 diagnosis codes recorded in the NIS
data set. These codes were then used to produce a summary Deyo index
score for each patient.
Study End Points
The primary end point of this study was in-hospital mortality; the sec-
ondary end point was rate of complications. All-cause in-hospital compli-
cations were recorded according to their ICD-9 diagnosis codes. The
following postoperative complications were assessed: cardiac complica-
tions, mediastinitis, neurologic complications, respiratory complications,
renal complications, deep vein thrombosis, pulmonary embolism, intrao-
perative complications, and iatrogenic pneumothorax (Appendix 1).
Statistical Analysis
Statistical analysis was performed with SPSS, version 19.0 (SPSS Inc,
Chicago, Ill). Multivariate analysis of variance tests and chi-square tests
were used to examine intergroup differences in age, race, sex, patient in-
come, expected payer, Deyo index score, mortality, length of hospital
stay, and disposition. We analyzed hospital characteristics including hospi-
tal volume, ownership, location (ie, rural vs urban), geographic region (ie,
Northeast, Midwest, West, and South), and bed size. Hospitals that per-
formed more than 25 AVR/CABG procedures per year were considered
high volume. To examine the risk-adjusted association between the pres-
ence of a TSRP and in-hospital complications and mortality, hierarchic
multiple logistic regression analysis was performed. With the regression
model, outcomes of patients who underwent AVR/CABG at non-
teaching hospitals and teaching hospitals without a TSRP were compared
with outcomes of patients who underwent the same procedure at a hospital
with a TSRP.
Because our sample was large, certain differences appeared to be statis-
tically significant even though their practical relevance was negligible.
Therefore, 3 different effect-size statistics were computed to assess the
practical implications of our findings. Cohen’s d was calculated for contin-
uous data by using pooled standard deviations and was appropriately
weighted for unequal sample size.9 The phi coefficient was calculatedrdiovascular Surgery c Volume 143, Number 3 649
TABLE 1. Excluded concomitant procedures and procedure codes
Procedure
Corresponding ICD-9-CM
procedure code(s)
Valve replacement: mitral 3523, 3524
Valvuloplasty 3510, 3511, 3512, 3513, 3514
Valve replacement: unspecified 3520, 3525, 3526, 3527, 3528
Papillary muscle excision 3531
Chordae excision 3532, 3535
Annuloplasty 3533
Infundibulectomy 3534
Creation of septal defect 3542
Endocushion defect repair 3550, 3551, 3552, 3553, 3554,
3570, 3571, 3572, 3573
Ventricular/atrial repair 3560, 3561, 3562, 3563
Congenital heart defect repair 3581, 3582, 3583, 3584, 3591,
3592, 3593, 3594, 3595, 3596,
3597, 3598, 3599
Transmyocardial
revascularization
3631, 3632
Ventricular restoration procedures 3732, 3733, 3734, 3735
Heart transplantation 3751, 3752, 3753, 3754
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freedom. Cramer’s V was computed for variables with more than 1 degree
of freedom.10 We used the following categories to judge the computed ef-
fect sizes: less than 0.32 (small), 0.33 to 0.55 (medium), and 0.56 or more
(large).
RESULTS
Patient Characteristics
Although there were several significant differences in the
baseline characteristics of patients who underwent AVR/
CABG at teaching versus nonteaching hospitals (Table 2),
the effect sizes of these differences were minuscule and
thus of no clinical consequence. The largest effect sizes
were observed for the difference in the distribution of hospital
bed size (Cramer’sV¼ 0.261), hospital ownership (Cramer’s
V ¼ 0.729), and hospital volume (Cramer’s V ¼ 0.269). A
higher proportion of patients (90%) underwent AVR/
CABG in large hospitals with a TRSP than in nonteaching
hospitals (87.5%) or teaching hospitals without a TSRP
(66.6%). Themajority of the procedures performed in hospi-
tals with a TSRP were at high-volume centers (92.2%).
Mortality
The in-hospital mortality rate—our primary outcome
measure—was higher at nonteaching hospitals (6.4%;
n ¼ 4195) than at teaching hospitals without a TSRP
(5.9%; n ¼ 4909) or at TSRP hospitals (5.9%; n ¼ 1413)
(P< .001). Nonetheless, after adjusting for confounding
factors, including the minor differences in baseline charac-
teristics, the components of the Deyo comorbidity index
scores, and hospital characteristics, we found no difference
in mortality for nonteaching hospitals (odds ratio [OR],
0.95; 95% confidence interval [CI], 0.87–1.04; P ¼ .25)650 The Journal of Thoracic and Cardiovascular Surgor teaching hospitals without a TSRP (OR, 1.00; 95% CI,
0.92–1.08; P ¼ .98) when compared with TSRP hospitals
(c-statistic ¼ 0.82).
Postoperative Complications
A robust risk-adjusted model with a c-statistic of 0.98
was used for regression analysis of the various postopera-
tive complications of patients who underwent AVR/
CABG in nonteaching hospitals and teaching hospitals
with or without a TSRP (Table 3). Patients who underwent
AVR/CABG had higher overall risk-adjusted complication
rates in nonteaching hospitals (OR, 1.58; 95% CI, 1.39–
1.80; P< .0001) and teaching hospitals without a TSRP
(OR, 1.42; 95% CI, 1.26–1.60; P< .0001) than in TSRP
hospitals. In addition, age, female gender, race, calendar
year, small hospital bed size, and case-specific hospital vol-
ume independently affected both in-hospital mortality and
morbidity. The regression coefficients are summarized in
Appendix 2.
DISCUSSION
For patients who underwent concomitant AVR/CABG,
a commonly performed yet complex cardiac operation,
the overall in-hospital complication rates were 58% higher
in nonteaching hospitals and 42% higher in teaching hos-
pitals without a TSRP than in hospitals with a TSRP. How-
ever, the risk-adjusted mortality was not different among
the 3 groups. Our results indicate that patients who undergo
complex procedures in hospitals with a TSRP may be at an
advantage.
Traditionally, academic medical centers have been pri-
marily focused on education and research in a setting that
also involves patient care. With cardiac surgical cases be-
coming increasingly complex, the number of straightfor-
ward resident ‘‘teaching cases’’ at academic medical
centers has declined. With the increased complexity of car-
diac cases, the outcomes of these patients are being sub-
jected to increased scrutiny with the application of risk
models and nationwide databases.
Studies that have compared surgical outcomes between
teaching and nonteaching hospitals have yielded controver-
sial findings. For example, Lee and colleagues11 found no
difference between teaching and nonteaching hospitals in
the outcome of pediatric patients treated for appendicitis.
However, Hayanga and colleagues12 showed that colon re-
section produced poorer outcomes when performed in
teaching hospitals than in nonteaching hospitals.
Our study showed no difference in mortality between
nonteaching hospitals and teaching hospitals with or with-
out a TSRP for patients who underwent combined AVR/
CABG. However, these patients had a lower complication
rate in hospitals with a TSRP. This may be because teaching
hospitals have multidisciplinary teams that are well equip-
ped to handle problems before they advance to anery c March 2012
TABLE 2. Patient baseline characteristics and demographics
Nonteaching
(n ¼ 65,407)
Teaching without TSRP
(n ¼ 83,414)
TSRP
(n ¼ 24,125) P Effect size
Age at admission (y) 72.45  9.27 72.53  9.60 72.56  9.90 <.179 <0.001*
Deyo comorbidity index score 3.95  1.53 3.93  1.57 3.99  1.60 <.001 <0.001*
Elective admission 52,879 (80.8) 63,736 (76.4) 18,358 (76.1) <.001 0.053y
Male 43,939 (67.2) 54,625 (65.5) 15,642 (64.8) <.001 0.019y
Race (Caucasian) 44,732 (91.2) 55,517 (91.1) 14,507 (86.2) <.001 0.056z
Hospital characteristics
Hospital bed size (large) 57,241 (87.5) 55,555 (66.6) 21,749 (90.1) <.001 0.261z
Hospital location (urban) 62,000 (94.8) 80,320 (96.3) 24,125 (100) <.001 0.087z
Hospital ownership (public) 22,372 (34.2) 82,042 (98.4) 24,125 (100) <.001 0.729z
Hospital volume (>25/y) 41,095 (62.8) 69,682 (83.5) 22,242 (92.2) <.001 0.269z
Intraaortic balloon pump 4461 (6.8) 4556 (5.5) 1521 (6.3) <.001 0.026y
Patient history
Peripheral vascular disease 6662 (10.2) 8035 (9.6) 2720 (11.3) <.001 0.018y
Myocardial infarction 190 (0.3) 297 (0.4) 108 (0.4) .001 0.009y
Congestive heart failure 21,219 (32.4) 25,801 (30.9) 8565 (35.5) <.001 0.033y
Cerebrovascular disease 5068 (7.8) 6683 (8.0) 1736 (7.2) <.001 0.01y
Chronic dementia 84 (0.1) 127 (0.1) 36 (0.1) .46 n/a
COPD 14,052 (21.5) 14,363 (17.2) 3672 (15.2) <.001 0.061y
Rheumatoid disorders 966 (1.5) 1256 (1.5) 435 (1.8) <.001 0.01y
Peptic ulcer disease 679 (1.0) 1015 (1.2) 317 (1.3) <.001 0.009y
Chronic mild liver disease 255 (0.4) 264 (0.3) 109 (0.5) .003 0.008y
Chronic moderate/severe liver
disease
91 (0.1) 59 (0.1) 53 (0.2) <.001 0.015y
Uncomplicated diabetes mellitus 13,569 (20.8) 16,949 (20.3) 5433 (22.5) <.001 0.018y
Diabetes with complications 1518 (2.3) 2040 (2.4) 644 (2.7) .010 0.007y
Preexisting hemiplegia or
paraplegia
365 (0.6) 437 (0.5) 76 (0.5) <.001 0.011y
Renal failure 2144 (3.3) 2799 (3.4) 728 (3.0) .034 0.006y
Data are presented as number (%) or as the mean standard deviation.COPD, Chronic obstructive pulmonary disease; n/a, not applicable (effect size is not applicable when there
is no statistically significant difference). *Cohen’s d was used to calculate effect size. yPhi was used to calculate effect size. zCramer’s V was used to calculate effect size.
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Dirreversible stage. In nonteaching settings, the perioperative
care of patients is handled by the primary surgeon or by an-
cillary staff members, such as physician assistants or nurse
practitioners. However, in a teaching hospital, residentsTABLE 3. Patient outcomes at nonteaching hospitals and teaching hospita
Nonteaching
(n ¼ 65,407)
Teaching with
(n ¼ 83
Cardiac complications 10,875 (16.6) 15,000 (
Systemic complications 900 (1.4) 981 (
Wound complications 1780 (2.7) 2297 (
GI complications 890 (1.4) 851 (
Operative complications 9402 (14.4) 11,824 (
Deep vein thrombosis 371 (0.6) 335 (
Infections 5109 (7.8) 7051 (
Mediastinitis 38 (0.1) 102 (
Neurologic complications 1966 (3.0) 2636 (
Pulmonary embolism 109 (0.2) 112 (
Pneumothorax 1292 (2.0) 2021 (
Respiratory complications 15,555 (23.8) 19,900 (
Renal complications 7545 (11.5) 9130 (
Any complication 33,564 (51.3) 42,886 (
Data are presented as number (%). GI, Gastrointestinal.
The Journal of Thoracic and Camanage the care of these patients. Although a lay person
seeking medical care would assume that the involvement
of a trainee physician would result in suboptimal care, our
study shows the contrary.ls with or without a thoracic surgery residency program
out TSRP
,414)
TSRP
(n ¼ 24,125) c2 P
18.0) 5460 (22.6) 430.3 <.001
1.2) 254 (1.1) 19.6 <.001
2.8) 869 (3.6) 55.7 <.001
1.0) 176 (0.7) 75.5 <.001
14.2) 3866 (16.0) 53.1 <.001
0.4) 187 (0.8) 56.1 <.001
8.5) 2701 (11.2) 261.1 <.001
0.1) 50 (0.2) 37.9 <.001
3.2) 639 (2.6) 16.8 <.001
0.1) 30 (0.1) 3.5 .175
2.4) 417 (1.7) 59.2 <.001
23.9) 5066 (21.0) 92.5 <.001
10.9) 2502 (10.4) 27.6 <.001
51.4) 12,975 (53.8) 48.5 <.001
rdiovascular Surgery c Volume 143, Number 3 651
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DRemaining at the forefront of medical care, teaching hos-
pitals are generally acquainted with the latest technologic
advancements and research developments. At non-
teaching hospitals, physicians and staff members are less
likely to stay abreast of these advancements because these
clinicians are overwhelmed with other priorities, such as fi-
nancial issues, maintaining referral relationships, book-
keeping, and, in many cases, direct involvement in floor
work. In an academic setting, these duties are delegated to
other personnel, thereby allowing academic surgeons to
spend more time not only on high-acuity patient care but
also on resident education and research. The active involve-
ment of the surgical team in research further ensures better
evidence-based care of postoperative patients with complex
needs. The lower complication rates that we observed in
teaching hospitals with a TSRP may directly result from
these institutional differences.
In support of these findings, our analysis showed that the
presence of a TSRP contributes to a lower rate of compli-
cations and a mortality rate equivalent to those of non-
teaching hospitals and teaching hospitals without
a TSRP. By definition, teaching hospitals in the NIS data-
base have at least one accredited residency program in
a medical or surgical field; from those hospitals, we specif-
ically selected those with a TSRP. At hospitals with
a TSRP, residents are more involved in the perioperative
aspects of cardiac surgery cases, which may partly explain
why the rate of morbidity was lower at these hospitals than
at teaching hospitals without a TSRP. The presence of
a TSRP was not detrimental or associated with a higher
rate of mortality.
Limitations
Our study is subject to the limitations inherent in a retro-
spective review. The Deyo comorbidity index does not cap-
ture variables such as the presence of aortic atheroma or
medical treatment (eg, concomitant antiplatelet therapy).
Therefore, when used for risk stratification, the Deyo co-
morbidity index may not reflect all of the important aspects
of the clinical scenario. In addition, the NIS is not a clinical
database, so details such as ejection fraction, severity of
congestive heart failure, intraoperative variables, indica-
tions, and precipitating factors for surgery were not avail-
able for risk-adjusted analysis. This is a significant
limitation of using administrative databases in clinical stud-
ies. Furthermore, because of the administrative nature of the
NIS database, there may have been reporting bias due to
coding errors. However, such a bias would have presumably
affected the 3 groups of patients equally. Nonetheless, be-
cause of this potential coding bias, we decided to limit
our outcome measures to concrete end points.
However, using the NIS has certain advantages. In addi-
tion to being nonvoluntary, which eliminates institutional
and surgeon bias, this nationwide database provides an652 The Journal of Thoracic and Cardiovascular Surgenormous sample size, which affords adequate statistical
power to detect low-frequency outcomes, such as
mortality.
Although our statistical model was adjusted for hospital
volume, it was not adjusted for surgeon volume. In the
NIS, surgeon identity is captured by individual surgeon or
surgical group, with significant year-to-year variation, mak-
ing a surgeon–volume adjustment impossible. Also, infor-
mation regarding the extent of resident involvement and
the participation of nurse practitioners or physician assis-
tants is not provided by the NIS dataset.
Another limitation of our study is that 29,717 patients
(14.7%) who underwent AVR/CABG at 136 teaching hos-
pitals were excluded because we were not able to determine
whether the teaching hospitals had a TSRP. In contrast, no
patients who underwent AVR/CABG in nonteaching hos-
pitals were excluded for any reason. Also, patient identifiers
are eliminated from the NIS dataset, making it impossible to
obtain valuable information such as 30-day mortality. The
possibility remains that patients in whom a complication
developed in nonteaching hospitals after AVR/CABG
may have been transferred to an academic or teaching facil-
ity for higher-level care or to a nursing home where they
may have died. Therefore, our study may underestimate
the rate of mortality for patients in nonteaching hospitals,
possibly explaining the lack of difference in mortality rates
among the 3 groups, despite significant differences in com-
plication rates. These issues introduce a significant selec-
tion bias that should be taken into consideration when
interpreting our findings.CONCLUSIONS
Patients who require complex cardiac operations such as
AVR/CABG may receive better surgical treatment at
teaching institutions with a TSRP. Despite the increasing
complexity of both cardiac surgical procedures and the
conditions they are performed to treat, resident involve-
ment continues to be an important and integral component
of patient care. The presence of residents in teaching hos-
pitals and in the academic environment contributes to
better patient outcomes in complex cardiac surgical proce-
dures, and our findings strongly support resident involve-
ment in all aspects of cardiac surgery at teaching
institutions.
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APPENDIX 1. Continued
Respiratory complications Postoperative atelectasis (997.3)
Postoperative pneumonia (486, 482.9, 482.89, 481, 482.0–482.2, 482.30–482.32,
482.39–482.41, 482.49, 482.81–482.83)
Postoperative acute respiratory insufficiency (518.5)
Postoperative acute pneumothorax (512.1)
Adult respiratory distress syndrome (518.5)
Postoperative pulmonary edema (518.4)
Empyema with fistula (510.0)
Empyema without fistula (510.9)
Pleural effusion (511.1, 511.8, 511.9)
Chronic respiratory failure (518.83)
Transfusion-related lung injury (518.7)
Lung abscess (513.0, 513.1)
Ventilator-associated pneumonia (997.31)
Procedure-related pneumonia (997.39).
Renal complications Oliguria or anuria due to procedure (997.5)
Acute renal failure (584)
Acute renal failure with tubular necrosis (584.5)
Acute renal failure with renal cortical necrosis (584.6)
Acute renal failure with papillary necrosis (584.7)
Acute renal failure with other specified pathology (584.8)
Acute renal failure with unspecified pathology (584.9)
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APPENDIX 2. Summary of covariates in logistic regression model predicting morbidity and mortality
Mortality Morbidity
B* P OR
95% CI for OR
B* P OR
95% CI for OR
Lower Upper Lower Upper
Age 0.019 <.001 1.019 1.016 1.023 0.037 <.001 1.038 1.033 1.042
Female gender 0.531 <.001 1.700 1.616 1.789 0.372 <.001 0.690 0.639 0.745
Intraaortic balloon pump 2.238 <.001 9.371 8.830 9.945 1.009 <.001 2.743 2.423 3.106
Primary payer 0.076 <.001 0.927 0.896 0.959 0.002 .926 1.002 0.959 1.048
Peripheral vascular disease 0.652 <.001 1.919 1.781 2.068 0.100 .065 1.105 0.994 1.229
Prior myocardial infarction 1.131 <.001 0.323 0.172 0.606 0.006 .986 1.006 0.515 1.965
Congestive heart failure 0.339 <.001 1.404 1.334 1.478 0.852 <.001 2.345 2.188 2.514
Cerebrovascular disease 0.322 <.001 1.379 1.268 1.501 0.137 .049 0.872 0.761 1.000
Chronic pulmonary disease 0.187 <.001 1.205 1.134 1.281 0.069 .124 1.071 0.981 1.169
Rheumatoid disorder 0.189 .109 0.828 0.657 1.043 0.814 <.001 0.443 0.305 0.643
Peptic ulcer disease 0.243 .014 1.276 1.050 1.550 0.002 .990 1.002 0.735 1.365
Mild liver disease 0.736 <.001 2.087 1.512 2.880 0.699 .003 2.011 1.266 3.196
Moderate liver disease 1.633 <.001 5.121 3.299 7.950 1.564 <.001 4.778 2.412 9.463
Diabetes mellitus 0.306 <.001 0.737 0.687 0.790 0.055 .187 0.947 0.872 1.027
Diabetic complications 0.145 .051 1.156 0.999 1.336 1.170 <.001 3.222 2.801 3.706
Hemiplegia or paraplegia 0.062 .681 0.940 0.700 1.263 1.508 <.001 4.520 2.821 7.242
Chronic kidney disease 0.675 <.001 1.965 1.752 2.204 1.395 <.001 4.035 3.572 4.558
Malignancy 0.076 .403 1.079 0.903 1.291 0.079 .469 1.082 0.875 1.338
Metastatic malignancy 0.161 .634 0.851 0.439 1.652 0.497 .280 0.608 0.247 1.500
Race (Caucasian) 0.203 <.001 0.816 0.754 0.884 0.137 .015 0.872 0.780 0.974
Calendar year 0.065 <.001 0.937 0.929 0.946 0.080 <.001 1.083 1.070 1.096
Small vs large hospital bed size 0.202 <.001 1.224 1.107 1.354 0.248 .001 0.780 0.672 0.906
Medium vs large hospital bed size 0.065 .076 1.068 0.993 1.147 0.336 <.001 0.715 0.642 0.796
High vs low hospital volume 0.191 <.001 0.826 0.775 0.880 0.286 <.001 1.331 1.214 1.459
Hospital location 0.129 .063 1.138 0.993 1.304 0.785 <.001 2.191 1.754 2.737
Hospital region (NE vs W) 0.102 .114 1.107 0.976 1.256 0.047 .568 0.954 0.812 1.121
Hospital region (MW vs W) 0.048 .476 1.050 0.919 1.199 0.084 .353 0.919 0.770 1.098
Hospital region (S vs W) 0.396 <.001 1.486 1.315 1.680 0.127 .109 1.136 0.972 1.327
Nonteaching vs teaching with TSRP 0.050 .255 0.951 0.873 1.037 0.459 <.001 1.582 1.390 1.801
Teaching without TSRP vs with TSRP 0.001 .976 1.001 0.924 1.085 0.353 <.001 1.424 1.263 1.604
CI, Confidence interval; OR, odds ratio; NE, Northeast; W, West; S, South; MW, Midwest. *Coefficient for regression model analysis.
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